These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9750385)

  • 41. Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. Evidence against persistent infection.
    Workowski KA; Lampe MF; Wong KG; Watts MB; Stamm WE
    JAMA; 1993 Nov; 270(17):2071-5. PubMed ID: 8305018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Urogenital infections due to gonococci and Chlamydia (other than Nicolas-Favre disease). Epidemiology, diagnosis, prognosis, treatment].
    Scrivener Y; Cribier B
    Rev Prat; 2001 Feb; 51(4):453-8. PubMed ID: 11355613
    [No Abstract]   [Full Text] [Related]  

  • 43. A comparison of diagnostic methods in adolescent girls with and without symptoms of Chlamydia urogenital infection.
    Biro FM; Reising SF; Doughman JA; Kollar LM; Rosenthal SL
    Pediatrics; 1994 Mar; 93(3):476-80. PubMed ID: 8115208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of an automated extraction method for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae by Cobas Amplicor PCR from different sample materials.
    Geertsen R; Friderich P; Dobec M; Emler S
    Scand J Infect Dis; 2007; 39(5):405-8. PubMed ID: 17464862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [SOME DIAGNOSTIC ASPECTS OF CHLAMYDIA TRACHOMATIS UROGENITAL INFECTIONS].
    Kovachev E; Bakardzhiev I; Pehlivanov G; Kolev N; Grueva E; Anzhel S
    Akush Ginekol (Sofiia); 2015; 54(8):8-12. PubMed ID: 27032228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosis of urogenital Chlamydia trachomatis infection by use of DNA amplification.
    Ostergaard L
    APMIS Suppl; 1999; 89():5-36. PubMed ID: 10189834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Seroepidemiologic study of sexually transmitted diseases caused by Chlamydia trachomatis in Casablanca (Morocco)].
    Bezian MC; Pelletier JR; Labrousse P; Diallo B; Bezian JH
    Bull Soc Pathol Exot; 1992; 85(2):125-9. PubMed ID: 1327348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chlamydia-induced reactive arthritis.
    Silveira LH; Gutiérrez F; Scopelitis E; Cuéllar ML; Citera G; Espinoza LR
    Rheum Dis Clin North Am; 1993 May; 19(2):351-62. PubMed ID: 8502776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening of Chlamydia trachomatis urogenital infections among the male and female population of the Republic of Macedonia.
    Spasovski MS; Simjanovska LJ; Taleski V; Petrova N; Lazetic L; Popeska Z; Gaydos CA; Quinn TC; Efremov GD
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):427-30. PubMed ID: 15987287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Noninvasive screening for genital chlamydiosis in adolescents in Brno].
    Pospísil L; Bucek R; Diblíková I; Drazd'áková M; Medková Z; Pejcoch M; Prosková Z; Unzeitig V; Vĕzník Z; Zralý Z
    Ceska Gynekol; 2000 Nov; 65(6):412-6. PubMed ID: 11272059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seroprevalence of Chlamydia trachomatis in Enugu, Nigeria.
    Ikeme AC; Ezegwui HU; Ikeako LC; Agbata I; Agbata E
    Niger J Clin Pract; 2011; 14(2):176-80. PubMed ID: 21860135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urogenital Chlamydia trachomatis strain types, defined by high-resolution multilocus sequence typing, in relation to ethnicity and urogenital symptoms among a young screening population in Amsterdam, The Netherlands.
    Versteeg B; Himschoot M; van den Broek IV; Bom RJ; Speksnijder AG; Schim van der Loeff MF; Bruisten SM
    Sex Transm Infect; 2015 Sep; 91(6):415-22. PubMed ID: 25688105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surveillance of community genital Chlamydia trachomatis testing in the East of England, 2008-2010.
    Jennison C; Roddick I; Deas A; Emmett L; Bracebridge S
    J Public Health (Oxf); 2011 Sep; 33(3):353-60. PubMed ID: 21252267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Urogenital infections caused by gonococci and chlamydia (Nicolas Favre disease excepted): epidemiology, diagnosis, course, treatment].
    Janier M
    Rev Prat; 1998 Apr; 48(8):905-8. PubMed ID: 11767338
    [No Abstract]   [Full Text] [Related]  

  • 55. [Herd immunity and the role of Chlamydia pneumoniae in the etiology of respiratory diseases in the Czech Republic].
    Sodja I; Bruj J; Svecová M; Kadlecík D; Mrázová M
    Epidemiol Mikrobiol Imunol; 1998 Feb; 47(1):27-31. PubMed ID: 9511284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic tests and specimens used to screen for Chlamydia trachomatis in genitourinary medicine clinics in the United Kingdom.
    David LM
    Int J STD AIDS; 1999 Aug; 10(8):527-30. PubMed ID: 10471102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diagnosis of urogenital infection by Chlamydia trachomatis. Contribution of genetic amplification techniques].
    Hamdad F; Orfila J
    Prog Urol; 2005 Sep; 15(4):598-601. PubMed ID: 16459669
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow?
    Schachter J; Stamm WE; Chernesky MA; Hook EW; Jones RB; Judson FN; Kellogg JA; LeBar B; Mårdh PA; McCormack WM
    Sex Transm Dis; 1992; 19(5):243-4. PubMed ID: 1344066
    [No Abstract]   [Full Text] [Related]  

  • 59. [Monitoring of microbiological and immunological disorders in urogenital chlamydiosis in people of reproductive age.].
    Omarova SM; Akhmedova RS; Bagandova DS; Akayeva FS; Muslimov MO; Isayeva RI
    Klin Lab Diagn; 2019; 64(1):46-48. PubMed ID: 30912884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A curious case of cancer or chlamydia?
    Atefi D; McNulty A; Varma R
    Intern Med J; 2021 Nov; 51(11):1975-1976. PubMed ID: 34796625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.